Zosano Pharma

About:

Zosano Pharma is a biopharmaceutical company, develops products based on the transdermal delivery technology.

Top Investors: Hercules Capital, New Enterprise Associates, Aisling Capital, BioMed Ventures, HBM Healthcare Investments

Description:

Zosano Pharma focuses on creating better products with its innovative drug delivery technology. Zosano's objective is to discover and develop therapeutic drug candidates that address large unmet medical needs or have a significant potential for commercialization. It was founded in 2006 and headquartered in Fremont, California.

Total Funding Amount:

$272M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Fremont, California, United States

Founded Date:

2006-10-01

Contact Email:

bd(AT)zosanopharma.com

Founders:

Peter Daddona

Number of Employees:

11-50

Last Funding Date:

2022-02-08

IPO Status:

Public

Industries: